Synonym
RO5256390; RO-5256390; RO 5256390. RO5256390 free base
IUPAC/Chemical Name
(S)-4-((S)-2-phenylbutyl)-4,5-dihydrooxazol-2-amine
InChi Key
IXDKFUBXESWHSL-JQWIXIFHSA-N
InChi Code
InChI=1S/C13H18N2O/c1-2-10(11-6-4-3-5-7-11)8-12-9-16-13(14)15-12/h3-7,10,12H,2,8-9H2,1H3,(H2,14,15)/t10-,12-/m0/s1
SMILES Code
NC1=N[C@@H](C[C@@H](C2=CC=CC=C2)CC)CO1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Related CAS#
1043495-96-0 (RO5256390 free base)
RO5256390 dihydrochloride CAS# is unknown.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
218.30
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Pei Y, Mortas P, Hoener MC, Canales JJ. Selective activation of the trace
amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents
cocaine-induced changes in brain reward thresholds. Prog Neuropsychopharmacol
Biol Psychiatry. 2015 Dec 3;63:70-5. doi: 10.1016/j.pnpbp.2015.05.014. Epub 2015
Jun 3. PubMed PMID: 26048337.
2: Pei Y, Lee J, Leo D, Gainetdinov RR, Hoener MC, Canales JJ. Activation of the
trace amine-associated receptor 1 prevents relapse to cocaine seeking.
Neuropsychopharmacology. 2014 Sep;39(10):2299-308. doi: 10.1038/npp.2014.88. Epub
2014 Apr 11. PubMed PMID: 24722355; PubMed Central PMCID: PMC4138750.
3: Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D, Metzler V, Chaboz
S, Groebke Zbinden K, Galley G, Norcross RD, Tuerck D, Bruns A, Morairty SR,
Kilduff TS, Wallace TL, Risterucci C, Wettstein JG, Hoener MC. A new perspective
for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like
activity, improve cognition and control body weight. Mol Psychiatry. 2013
May;18(5):543-56. doi: 10.1038/mp.2012.57. Epub 2012 May 29. PubMed PMID:
22641180.